GSK Acquires Experimental Multiple Myeloma Drug from Chimagen for Up to $750 Million
The trispecific T-cell engager is designed to target two tumor antigens and is expected to enter phase 1 trials in 2027.
U.S. News Releases 20th Annual Best Children's Hospitals Rankings
Eleven hospitals made the Honor Roll, with Boston Children's ranking first in seven specialties including cancer treatment.
Small Phone Bill Fees Double State Funding for Suicide Prevention Services
Twelve states charge about 30 cents per line monthly to fund 988 crisis lines, new study shows.
Brain Implant Lets Paralyzed Patients Control Avatar With Speech and Gestures Simultaneously
Three ALS patients used brain signals to control avatars using 10 words and 10 gestures in the first system enabling both at once.
Abbott to Pay $385 Million Over Infant Formula Plant Safety Allegations
The settlement concerns unsanitary conditions at a Michigan facility that led to a 2022 recall and nationwide formula shortage.
Definium's LSD-Based Anxiety Drug Succeeds in Second Late-Stage Trial
DT120, a single-dose lysergide tablet, reduced anxiety scores by 5.1 points more than placebo after 12 weeks in 245-patient study.
AstraZeneca breast cancer pill fails to meet goal in late-stage trial
Camizestrant did not delay disease progression more than standard treatment in patients with advanced breast cancer.
Unvaccinated Woman Dies of Measles Complications in Pennsylvania Outbreak
The 40-year-old woman is the third measles-related death in Pennsylvania this year, as the state reports 676 cases.
Two lung cancer drug combinations show early promise in clinical trials
Studies presented at a Seoul conference evaluated new treatments for small cell lung cancer, including novel antibody combinations and delivery methods.
Create your account.
One account for both. Start free in under three minutes.
Free
The morning brief in your inbox, built from what you follow.
Premium · $8.99/month
The same brief as your own daily podcast, ready every morning.
Free account, no card required. The podcast upgrade comes later.